Voloridge Investment Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,170
Closed -$1.68M 1924
2021
Q3
$1.68M Buy
+5,170
New +$1.75M 0.01% 1105
2021
Q1
Sell
-71,949
Closed -$23.3M 1732
2020
Q4
$23.3M Sell
71,949
-45,696
-39% -$12.6M 0.2% 120
2020
Q3
$32.6M Buy
117,645
+53,327
+83% +$15.4M 0.27% 89
2020
Q2
$15.5M Sell
64,318
-13,244
-17% -$2.66M 0.18% 115
2020
Q1
$11.3M Buy
77,562
+35,871
+86% +$5.95M 0.32% 63
2019
Q4
$7.11M Sell
41,691
-27,741
-40% -$5.14M 0.14% 190
2019
Q3
$12.4M Buy
69,432
+17,003
+32% +$3.68M 0.21% 94
2019
Q2
$13.7M Buy
52,429
+21,428
+69% +$5.69M 0.38% 51
2019
Q1
$8.85M Sell
31,001
-8,106
-21% -$2.69M 0.27% 78
2018
Q4
$12.7M Sell
39,107
-18,506
-32% -$6.43M 0.58% 43
2018
Q3
$25.9M Sell
57,613
-7,651
-12% -$3.02M 0.56% 51
2018
Q2
$26.7M Buy
65,264
+23,045
+55% +$8.35M 0.72% 30
2018
Q1
$12.3M Buy
42,219
+18,060
+75% +$4.58M 0.29% 57
2017
Q4
$4.53M Buy
+24,159
New +$4.51M 0.1% 217
2016
Q4
Sell
-51,547
Closed -$6.63M 684
2016
Q3
$6.63M Buy
+51,547
New +$6.17M 0.14% 93
2015
Q4
Sell
-40,332
Closed -$3.74M 338
2015
Q3
$3.74M Buy
+40,332
New +$3.55M 0.18% 134

Other funds holding ABMD

Voloridge Investment Management's ABMD Position: Q4 2021 in Review

Voloridge Investment Management sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 5,170 shares — an estimated $1.68M sold.

Voloridge Investment Management first reported a position in ABMD in Q3 2015 and held it in 16 quarters. The position peaked at $32.6M in Q3 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Voloridge Investment Management reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 5,170 Abiomed Inc shares in Q4 2021, an estimated $1.68M.
  • Voloridge Investment Management first reported a position in Abiomed Inc in Q3 2015 and held it in 16 quarters.
  • Voloridge Investment Management's Abiomed Inc position peaked at $32.6M in Q3 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Voloridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.